Cargando…
lncRNA HCG11 suppresses cell proliferation in hormone receptor-positive breast cancer via SRSF1/β-catenin
Hormone receptor positive (HR-positive) breast cancer (BC) is the most common subtype of breast cancer. Despite adjuvant endocrine therapy and chemotherapy-based treatment, the therapeutic response is often not satisfactory in HR-positive BC patients. Therefore, elucidating the mechanisms that regul...
Autores principales: | Xie, Dan, Li, Saiyang, Wang, Xuehui, Fang, Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9876628/ https://www.ncbi.nlm.nih.gov/pubmed/36602530 http://dx.doi.org/10.18632/aging.204468 |
Ejemplares similares
-
lncRNA HCG11 suppresses human osteosarcoma growth through upregulating p27 Kip1
por: Gu, Jie, et al.
Publicado: (2021) -
A Novel LncRNA, AC091729.7 Promotes Sinonasal Squamous Cell Carcinomas Proliferation and Invasion Through Binding SRSF2
por: Yu, Boyu, et al.
Publicado: (2020) -
LncRNA HCG11 Suppresses Cell Proliferation and Promotes Apoptosis via Sponging miR-224-3p in Non-Small-Cell Lung Cancer Cells
por: Wang, Guige, et al.
Publicado: (2020) -
LncRNA DACH1 protects against pulmonary fibrosis by binding to SRSF1 to suppress CTNNB1 accumulation
por: Sun, Jian, et al.
Publicado: (2022) -
LncRNA TMEM220-AS1 suppresses hepatocellular carcinoma cell proliferation and invasion by regulating the TMEM220/β-catenin axis
por: Liu, Yang, et al.
Publicado: (2021)